Skip to content
DraconiticResearch
Search Sources API
174,684 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Association between maternal antimony exposure and offspring congenital heart defects: findings from a large birth cohort study

  • Yawen Shao1
  • Lei Cao2,3
  • Ru Lin1
  • Jie Ran1
  • Qing Liu4
  • Baohong Mao2,3
4 affiliations
  1. 1Cervical Cancer Prevention and Treatment Center, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Central Hospital)
  2. 2Department of Medical Education, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Central Hospital)
  3. 3School of Public Health, Gansu University of Chinese Medicine
  4. 4Department of Obstetrics and Gynecology, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Central Hospital)
Read full textPDFDOICite

Abstract

Background: This nested case–control study aimed to investigate the association between maternal blood antimony concentrations and the risk of congenital heart defects (CHDs) in offspring, identify potential risk factors for CHDs, and inform prevention strategies.

Method: The study was conducted within a birth cohort established jointly by Gansu Provincial Maternity and Child Care Hospital and Yale University. A total of 291 women were enrolled, including 97 women who gave birth to infants with CHDs (case group) and 194 controls. Controls were selected from the same cohort using a 1:2 matching ratio and matched to cases by age and community. Maternal whole blood samples were collected during prenatal hospitalization before delivery, and antimony concentrations were measured by inductively coupled plasma mass spectrometry (ICP-MS). Receiver operating characteristic (ROC) curve analysis was used to determine an antimony exposure cutoff and classify participants into high and low exposure groups. Conditional multivariable logistic regression was performed to assess the association between maternal blood antimony concentrations and the risk of CHDs in offspring.

Results: The mean maternal blood antimony concentration was 13.05 μg/L in the control group and 20.30 μg/L in the CHDs group, and the difference between the two groups was statistically significant. Compared with the low exposure group, the high exposure group was associated with a significantly higher risk of CHDs in offspring (OR = 4.455, 95% CI: 2.029–9.782). Similar associations were observed for the subgroups of isolated CHDs, great arteries malformation, septal defects, and atrial septal defects (ASDs). For each 6 μg/L increment in maternal blood antimony, a 38.9% higher risk of CHDs in offspring (OR = 1.389, 95% CI: 1.110–1.735), with consistent findings in the isolated CHDs, septal defects, and ASDs subgroups. Restricted cubic spline (RCS) analysis showed that when maternal blood antimony exceeded 18.409 μg/L, CHDs risk in offspring increased with rising antimony levels.

Conclusion: Higher maternal blood antimony concentrations were associated with an increased risk of CHDs in offspring. These findings suggest that the prenatal living environment may be a modifiable target for CHD prevention and warrant efforts to minimize exposure to potential environmental sources of antimony.

Related

  1. Effects of Maternal Caffeine Exposure During Gestation on Neurobehavior, Glucose Metabolism and Circadian Rhythm in Offspring Rats
    Minying Sun, Huanxin Pan, Guangyu Yang +4
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. First-trimester maternal exposures and offspring congenital heart defects: a Hungarian population-based case–control study, 1980–2009
    Zihan Suo, Alex Váradi, Péter Hegyi +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiersCrossref
  3. Preconception maternal infection-related exposures and risk of congenital heart disease in offspring: evidence from a large population-based cohort in South China
    Yanbing Chen, Rong Xu, Huili Wei +6
    BMC Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  4. Risk of orofacial clefts in offspring following maternal exposure to anti-seizure medications in a UK CPRD GOLD observational study
    Kritika Jain, Amy J. V. Davies, Sarah J. Lewis +11
    Scientific ReportsPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  5. Maternal HFD and CDAHFD Exposure from Pregnancy to Lactation Differentially Affect Lipid Profiles and Behavior in Offspring Mice
    Ryoken Aoki, Nobuo Izumo, Megumi Furukawa +4
    NutrientsPeer-reviewedCC BY 4.0NutritionCrossref

Cite

BibTeXRIS
BibTeX
@article{shao2026association,
  title = {{Association between maternal antimony exposure and offspring congenital heart defects: findings from a large birth cohort study}},
  author = {Yawen Shao and Lei Cao and Ru Lin and Jie Ran and Qing Liu and Baohong Mao},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = oct,
  doi = {10.3389/fpubh.2026.1957018},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1957018/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association between maternal antimony exposure and offspring congenital heart defects: findings from a large birth cohort study
AU  - Yawen Shao
AU  - Lei Cao
AU  - Ru Lin
AU  - Jie Ran
AU  - Qing Liu
AU  - Baohong Mao
PY  - 2026
DA  - 2026/10/19
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1957018
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1957018/full
AB  - Background: This nested case–control study aimed to investigate the association between maternal blood antimony concentrations and the risk of congenital heart defects (CHDs) in offspring, identify potential risk factors for CHDs, and inform prevention strategies.  Method: The study was conducted within a birth cohort established jointly by Gansu Provincial Maternity and Child Care Hospital and Yale University. A total of 291 women were enrolled, including 97 women who gave birth to infants with CHDs (case group) and 194 controls. Controls were selected from the same cohort using a 1:2 matching ratio and matched to cases by age and community. Maternal whole blood samples were collected during prenatal hospitalization before delivery, and antimony concentrations were measured by inductively coupled plasma mass spectrometry (ICP-MS). Receiver operating characteristic (ROC) curve analysis was used to determine an antimony exposure cutoff and classify participants into high and low exposure groups. Conditional multivariable logistic regression was performed to assess the association between maternal blood antimony concentrations and the risk of CHDs in offspring.  Results: The mean maternal blood antimony concentration was 13.05 μg/L in the control group and 20.30 μg/L in the CHDs group, and the difference between the two groups was statistically significant. Compared with the low exposure group, the high exposure group was associated with a significantly higher risk of CHDs in offspring (OR = 4.455, 95% CI: 2.029–9.782). Similar associations were observed for the subgroups of isolated CHDs, great arteries malformation, septal defects, and atrial septal defects (ASDs). For each 6 μg/L increment in maternal blood antimony, a 38.9% higher risk of CHDs in offspring (OR = 1.389, 95% CI: 1.110–1.735), with consistent findings in the isolated CHDs, septal defects, and ASDs subgroups. Restricted cubic spline (RCS) analysis showed that when maternal blood antimony exceeded 18.409 μg/L, CHDs risk in offspring increased with rising antimony levels.  Conclusion: Higher maternal blood antimony concentrations were associated with an increased risk of CHDs in offspring. These findings suggest that the prenatal living environment may be a modifiable target for CHD prevention and warrant efforts to minimize exposure to potential environmental sources of antimony.
SN  - 2296-2565
ER  -